Screener
Odyssey Therapeutics ODTX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q2 '25 | ||
|---|---|---|---|---|
| -$52.79M-28.0% | -$38.26M+0.5% | -$41.24M— | ||
| $1.04M-17.7% | $1.17M-9.9% | $1.27M— | ||
| $5.67M+53.4% | $2.59M-13.4% | $3.7M— | ||
| -$34.51M-0.7% | -$41.04M-6.3% | -$34.26M— | ||
| $186K+541% | $148K-84.0% | $29K— | ||
| -$211.44M-1,007% | $34.8M+2.0% | $23.31M— | ||
| $292.16M+146% | $484K+142% | $118.72M— | ||
| $46.31M-57.2% | -$5.73M-35.5% | $108.09M— | ||
| -$34.69M-1.2% | -$41.18M-4.1% | -$34.29M— |
FAQ
- How much cash does Odyssey Therapeutics generate?
- Odyssey Therapeutics (ODTX) generated -$148.4M in operating cash flow over the trailing twelve months.
- What is Odyssey Therapeutics's free cash flow?
- After $1.3M of capital expenditures, Odyssey Therapeutics's free cash flow was -$149.7M over the trailing twelve months.
- Where does Odyssey Therapeutics's cash flow data come from?
- Every line is extracted from Odyssey Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
